2017 Kidney Disease: Improving Global Outcomes (KDIGO) guideline [6] recommends maintaining intact PTH levels in the range of approximately 2 to 9 times the upper normal limit for the assay in patients with CKD G5D. This evidence concerns the gene PTH and chronic kidney disease.